Brian Burkavage
CIK 1865633 · Chief Accounting Officer · last filed 2025-04-04
Brian Burkavage is a Chief Accounting Officer who has filed 5 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for IOBT, was dated Apr 4, 2025. Across all open-market trades the lifetime net is +$10.1K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
5
$10.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IO Biotech, Inc. (IOBT) Delisted | Chief Accounting Officer | 11,500 | $0.05 | $552 | $10.1K | 5 | 2025-04-04 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-04-04 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-18 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-11-24 | IO Biotech, Inc. (IOBT) Delisted | Buy (P) | +10,000 | $10.1K | EDGAR |
| 2023-03-22 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-02 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |